When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...

Bioprocessing is an umbrella term that describes the research, development, manufacturing, and commercialization of products derived from or used by biological systems. For industrial purposes, ...

A Contamination Control Strategy (CCS) identifies and evaluates contamination risks, explores mitigation options, and sets out plans for corrective and preventive actions. Its implementation addresses ...

DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Drug Benefit Design Report, sponsored by Prescryptive Health, detailing the trends and ...

DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, has added two significant enhancements to its leadership team aimed at further empowering healthcare payers and ...

In today’s Pharmaceutical Executive Daily, Hims & Hers withdraws access to its compounded semaglutide pill following a controversy filled launch, next-generation trial designs increasingly integrate ...

State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture has the following research output in the current window (1 November 2024 - 31 ...

EMS is one of the most hands‑on and practical automation systems in pharma. It is simultaneously about engineering, regulatory requirements and operator convenience. Proper architecture (local logic ...

While pharmaceutical companies invest millions in drug development and commercialization, many overlook the critical connection between their products and patients: the pharmacy. This blind spot can ...